Summary
Checkpoint inhibitors for treating cancer is a type of drug that blocks certain proteins made by some types of immune system cells, such as T cells, and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are blocked, the “brakes” on the immune system are released and T cells are able to kill cancer cells better. Examples of checkpoint proteins found on T cells or cancer cells include PD-1/PD-L1 and CTLA-4/B7-1/B7-2.
Market Segment as follows:
By Type
PD-1 inhibitors
PD-L1 inhibitors
CTLA-4 inhibitors
By Application
Melanoma treatment
Bladder cancer treatment
Others
By Company
Bristol-Myers Squibb(BMS)
Merck
Roche
The main contents of the report including:
Section 1:
Product definition, type and application, global and China market overview;
Section 2:
Global and China Market competition by company;
Section 3:
Global and China sales revenue, volume and price by type;
Section 4:
Global and China sales revenue, volume and price by application;
Section 5:
China export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
Interested in this report?
Get your sample now!
Table of Content
1 Market Overview
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 PD-1 inhibitors
1.1.2.2 PD-L1 inhibitors
1.1.2.3 CTLA-4 inhibitors
1.1.3 Market by Application
1.1.3.1 Melanoma treatment
1.1.3.2 Bladder cancer treatment
1.1.3.3 Others
1.2 Global and China Market Size
1.2.1 Global Overview
1.2.2 China Overview
2 Global and China Market by Company
2.1 Global
2.1.1 Global Sales by Company
2.1.2 Global Price by Company
2.2 China
2.2.1 China Sales by Company
2.2.2 China Price by Company
3 Global and China Market by Type
3.1 Global
3.1.1 Global Sales by Type
3.1.2 Global Price by Type
3.2 China
3.2.1 China Sales by Type
3.2.2 China Price by Type
4 Global and China Market by Application
4.1 Global
4.1.1 Global Sales by Application
4.1.2 Global Price by Application
4.2 China
4.2.1 China Sales by Application
4.2.2 China Price by Application
5 China Trade
5.1 Export
5.2 Import
6 Key Manufacturers
6.1 Bristol-Myers Squibb(BMS)
6.1.1 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Merck
6.3 Roche
7 Industry Upstream
7.1 Industry Chain
7.2 Raw Materials
8 Market Environment
8.1 SWOT
8.2 Porter's Five Forces
9 Conclusion
Figure PD-1 inhibitors Market Size and CAGR 2013-2018 (Million USD)
Figure PD-1 inhibitors Market Size and CAGR 2013-2018 (Volume)
Figure PD-1 inhibitors Market Forecast and CAGR 2019-2025 (Million USD)
Figure PD-1 inhibitors Market Forecast and CAGR 2019-2025 (Volume)
Figure PD-L1 inhibitors Market Size and CAGR 2013-2018 (Million USD)
Figure PD-L1 inhibitors Market Size and CAGR 2013-2018 (Volume)
Figure PD-L1 inhibitors Market Forecast and CAGR 2019-2025 (Million USD)
Figure PD-L1 inhibitors Market Forecast and CAGR 2019-2025 (Volume)
Figure CTLA-4 inhibitors Market Size and CAGR 2013-2018 (Million USD)
Figure CTLA-4 inhibitors Market Size and CAGR 2013-2018 (Volume)
Figure CTLA-4 inhibitors Market Forecast and CAGR 2019-2025 (Million USD)
Figure CTLA-4 inhibitors Market Forecast and CAGR 2019-2025 (Volume)
Figure Melanoma treatment Market Size and CAGR 2013-2018 (Million USD)
Figure Melanoma treatment Market Size and CAGR 2013-2018 (Volume)
Figure Melanoma treatment Market Forecast and CAGR 2019-2025 (Million USD)
Figure Melanoma treatment Market Forecast and CAGR 2019-2025 (Volume)
Figure Bladder cancer treatment Market Size and CAGR 2013-2018 (Million USD)
Figure Bladder cancer treatment Market Size and CAGR 2013-2018 (Volume)
Figure Bladder cancer treatment Market Forecast and CAGR 2019-2025 (Million USD)
Figure Bladder cancer treatment Market Forecast and CAGR 2019-2025 (Volume)
Figure Others Market Size and CAGR 2013-2018 (Million USD)
Figure Others Market Size and CAGR 2013-2018 (Volume)
Figure Others Market Forecast and CAGR 2019-2025 (Million USD)
Figure Others Market Forecast and CAGR 2019-2025 (Volume)
Figure Global Checkpoint Inhibitors for Treating Cancer Market Size and CAGR 2013-2017 (Million USD)
Figure Global Checkpoint Inhibitors for Treating Cancer Market Size and CAGR 2013-2017 (Volume)
Figure Global Checkpoint Inhibitors for Treating Cancer Market Forecast and CAGR 2019-2025 (Million USD)
Figure Global Checkpoint Inhibitors for Treating Cancer Market Forecast and CAGR 2019-2025 (Volume)
Figure China Checkpoint Inhibitors for Treating Cancer Market Size and CAGR 2013-2017 (Million USD)
Figure China Checkpoint Inhibitors for Treating Cancer Market Size and CAGR 2013-2017 (Volume)
Figure China Checkpoint Inhibitors for Treating Cancer Market Forecast and CAGR 2019-2025 (Million USD)
Figure China Checkpoint Inhibitors for Treating Cancer Market Forecast and CAGR 2019-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure China Market Sales Revenue Share by Company in 2017
Figure China Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure China Market Sales Revenue Share by Type in 2017
Figure China Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure China Market Sales Revenue Share by Application in 2017
Figure China Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Checkpoint Inhibitors for Treating Cancer SWOT List
Figure Checkpoint Inhibitors for Treating Cancer Porter's Five Forces
